(1 - 8 von 8
)
Shake-up at AstraZeneca as two immuno-oncology leaders leave | Reuters
www.reuters.com
* Immune-boosting cancer drugs critical to company's future
AZ taps new immuno-oncology leader as two valued veterans depart |...
www.biopharmadive.com
BioPharma
LABEST | UCLA TDG
tdg.ucla.edu
Peter Emtage gestures as he speaks from the stage. Peter Emtage, Senior Vice President, Head of Cell Therapy Research, Kite, A Gilead Company.
CAR-TCR Summit [ ]
www.thebostoncalendar.com
The CAR-TCR Summit remains at the forefront of the industry bringing you never-seen-before data from the movers and shakers in CAR and TCR therapy...
Cell Design Labs – MBC BioLabs
mbcbiolabs.com
The early team included Brian Atwood, CEO, Peter Emtage, and two scientists from Lim's lab, Levi Rupp and Scott Coyle. Our labs were perfect ...
Gilead Sciences to Acquire Cell Design Labs
www.globenewswire.com
– Demonstrates Gilead’s Deep Commitment to Cell Therapy – – Novel Cell Engineering Technologies with the Potential to Drive Discovery and Development of...
Loop | CAR-TCR Summit 2019
www.frontiersin.org
... Katherine Szarama, Evidence Development Division, Centers for Medicare and Medicaid Services ; Peter Emtage Senior Vice President and ...
Moving forward with Cell Design Labs | Drug Discovery News
www.drugdiscoverynews.com
Gilead and Kite announce plans to acquire the preclinical custom cell engineering company
sortiert nach Relevanz / Datum